# Clinical trials recruiting in Martinique: 25 (November 2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 25 trials recruiting or not yet recruiting with a site in Martinique, as read on November 19, 2026.

## The full list

Clinical trials recruiting in Martinique: 25 rows for $5, recruiting or not yet recruiting on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email.

Buy: https://specstream.ai/data/clinical-trials/recruiting/country/martinique

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 25
- Recruiting or not yet: 25
- Read on: November 19, 2026

## Trials

The 25 newest of 25, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| July 29, 2026 | NCT07733206 | Validation of a Capillary Leak Index During Septic Shock, Based on Haemoglobin Level Variations Induced by Fluid Resuscitation. A Pilot... | University Hospital Center of Martinique | Not applicable | Not yet recruiting | Sepsis | 100 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07733206) |
| December 2, 2025 | NCT07257289 | Stratification of Arrhythmic Risk and/or Heart Failure Risk in Patients With Hereditary Heart Disease | Nantes University Hospital | Observational | Recruiting | Hereditary Heart Diseases | 1,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07257289) |
| October 3, 2025 | NCT07206927 | Analysis of the Determinants of the Participation of Patients and Health Professionals of the University Hospital Center of Martinique in... | University Hospital Center of Martinique | Observational | Not yet recruiting | Oncologic Diseases, Cancer, Oncology | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07206927) |
| June 12, 2025 | NCT07018180 | Interventional Clinical Trial Evaluating COVER PATCH CAPTEUR PROTECT Support Solutions for Continuous Glucose Monitoring Sensors in... | Sponsor not shown (see the record) | Not applicable | Recruiting | Diabetes | 194 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07018180) |
| April 3, 2025 | NCT06909591 | Transcultural and Psychometric Validation of the Lubben Social Network Scale in Older Adults Living in the French West Indies | University Hospital Center of Martinique | Observational | Not yet recruiting | Geriatric Assessment, Patients Over 65 Years Old | 150 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06909591) |
| January 14, 2025 | NCT06773806 | CHLORDECONE EXPOSURE AND PROSTATE CANCER IN THE FRENCH REGION OF MARTINIIQUE | Institut National de la Santé Et de la Recherche Médicale, France | Observational | Recruiting | Prostate Cancer | 3,600 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06773806) |
| October 3, 2024 | NCT06625970 | Study Evaluating the Efficacy and Safety of Darolutamide and Stereotactic Dose Escalated Radiotherapy in Patients With Localized Prostate... | UNICANCER | Phase 3 | Recruiting | High Risk Prostate Carcinoma, Prostate Cancer | 700 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06625970) |
| August 21, 2024 | NCT06563895 | Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant | Eidos Therapeutics, a BridgeBio company | Phase 3 | Recruiting | Amyloidosis, Amyloid Cardiomyopathy, Transthyretin Amyloidosis, Cardiomyopathies, Heart Diseases, Polyneuropathies | 587 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06563895) |
| July 29, 2024 | NCT06525012 | Observational Study on Mortality and Outcome of Patients Hospitalized for Subarachnoid Hemorrhage of Aneurysmal Origin in Martinique... | University Hospital Center of Martinique | Observational | Recruiting | Subarachnoid Hemorrhage of Aneurysmal Cause | 122 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06525012) |
| March 4, 2024 | NCT06291025 | Efficacy and Safety of Immunosuppression, Caplacizumab and Plasma Infusion Without Therapeutic Plasma Exchange in Immune-mediated... | University Hospital, Rouen | Not applicable | Recruiting | Thrombotic Microangiopathies | 131 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06291025) |
| August 16, 2023 | NCT05995171 | Long Term Outcome of Easophageal Atresia : Transmics Profiles in Adolescence | University Hospital, Lille | Observational | Recruiting | Esophageal Atresia | 300 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05995171) |
| August 8, 2023 | NCT05982132 | Weight Changes Among Martinican Prisoners | University Hospital Center of Martinique | Observational | Recruiting | Weight Gain, Weight Loss | 227 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05982132) |
| January 17, 2023 | NCT05686850 | Non-Invasive Ventilation Versus High-flow Nasal Oxygen in Intensive Care Units | Poitiers University Hospital | Not applicable | Recruiting | Post Extubation Respiratory Failure | 670 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05686850) |
| December 27, 2022 | NCT05665608 | Prevention Of Sudden Cardiac Death After Myocardial Infarction by Defibrillator Implantation | Charite University, Berlin, Germany | Not applicable | Recruiting | Sudden Cardiac Death, Myocardial Infarction | 3,595 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05665608) |
| January 21, 2022 | NCT05200715 | AutoInflammatory Disease Alliance Registry (AIDA) | University of Siena | Observational | Recruiting | Hereditary Autoinflammatory Diseases, Schnitzler Syndrome, Behcet Syndrome, PFAPA Syndrome, Still Disease... | 3,500 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05200715) |
| July 2, 2021 | NCT04949737 | Prevalence of Helicobacter Pylori Infection and Gastric Cancer in the West Indies | University Hospital Center of Martinique | Observational | Recruiting | Stomach Neoplasms, Gastric Neoplasms, Helicobacter Pylori | 112 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04949737) |
| June 7, 2021 | NCT04916613 | ADT +/- Darolutamide in de Novo Metastatic Prostate Cancer Patients With Vulnerable Functional Ability (PEACE6-Vulnerable) | UNICANCER | Phase 3 | Recruiting | Prostate Cancer Metastatic | 300 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04916613) |
| April 9, 2021 | NCT04839757 | Dengue Vaccine Strategy in Children Aged 9 to 17 Years in the French Caribbean | University Hospital Center of Martinique | Observational | Recruiting | Dengue, Vaccination, Seroprevalence, Infectious Disease | 590 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04839757) |
| August 31, 2020 | NCT04533152 | Prognostic Determinants in Patients With Diabetic Foot Ulcer. | University Hospital, Bordeaux | Observational | Recruiting | Diabetic Foot Ulcer | 1,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04533152) |
| December 26, 2019 | NCT04211649 | Comparing Two Antibiotic Therapy Periods (3 Versus 7 Days) in Patients With Mild Leptospirosis and Seen at the Hospital in 5 French... | University Hospital Center of Martinique | Phase 4 | Not yet recruiting | Mild Leptospirosis | 220 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04211649) |
| April 2, 2019 | NCT03900221 | French Registry for Monitoring Pregnancies for Multiple Sclerosis | Hospices Civils de Lyon | Observational | Recruiting | Sclerosis, Multiple, Neuromyelitis Optica Spectrum Disorder, Myelin Oligodendrocyte Glycoprotein (MOG)-Antibody Related... | 1,500 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03900221) |
| January 7, 2019 | NCT03795376 | Dat'Aids Prevention | Sponsor not shown (see the record) | Observational | Recruiting | HIV Prevention | 6,500 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03795376) |
| September 13, 2016 | NCT02898987 | Quality of Care in French HIV Infected Patients | Sponsor not shown (see the record) | Observational | Recruiting | HIV | 30,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02898987) |
| September 21, 2012 | NCT01689584 | COsegregation of VARiants in Panel of Genes | Institut Curie | Not applicable | Recruiting | Gene Mutation-Related Cancer, Genetic Predisposition | 11,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01689584) |
| May 15, 2009 | NCT00903110 | Global Patient Registry to Monitor Long-term Safety and Effectiveness of Increlex® in Children and Adolescents With Severe Primary... | Esteve Pharmaceuticals, S.A. | Observational | Recruiting | IGF1 Deficiency | 500 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00903110) |

## Sites with the most of these trials

Sites as the records name them, organizations only.

| Site | City | Trials |
| --- | --- | --- |
| CHU Martinique | Fort-de-France | 3 |
| University Hospital Center of Martinique | Fort-de-France | 2 |
| CHU de Martinique | Fort-de-France | 2 |
| CHU de Fort de France | Fort-de-France | 2 |
| CHU de la Martinique | Fort-de-France | 2 |
| CHU of Martinique | Fort-de-France | 1 |
| Centre Hospitalier Universitaire de Martinique | Fort-de-France | 1 |
| Pierre Zobda Quitman Hospital | Fort-de-France | 1 |
| Le Centre Hospitalier Universitaire de Martinique | Fort-de-France Cedex | 1 |
| The private clinic "Clinique Saint-Paul" | Fort-de-France | 1 |
| University Hospital of Martinique (CHUM) | Fort-de-France | 1 |
| CHU Fort de France | Fort-de-France | 1 |
| Hopital P. Zobda-Quitman | Fort-de-France | 1 |
| Chu Martinique | Fort-de-France | 1 |
| Hôpital Pierre Zobda Quitman | Fort-de-France | 1 |
| University Hospital of Martinique | Fort-de-France | 1 |
| CHU de la Martinique - Hôpital Albert Clarac | Fort-de-France | 1 |
| Martinique University Hospital Center | Fort-de-France | 1 |
| CHU Martinique - Hôpital Pierre Zobda Quitman 1 | Fort-de-France | 1 |

## By phase

| Phase | Trials |
| --- | --- |
| Phase 3 | 3 |
| Phase 4 | 1 |
| Not applicable | 6 |
| Observational | 15 |

## Conditions

| Condition group | Trials |
| --- | --- |
| Prostatic Neoplasms | 2 |
| Diabetes Mellitus | 2 |
| Neoplasms | 1 |
| Stomach Neoplasms | 1 |
| Respiratory Insufficiency | 1 |
| Genetic Predisposition to Disease | 1 |
| Death, Sudden, Cardiac | 1 |
| Myocardial Infarction | 1 |
| Esophageal Atresia | 1 |
| Hepatitis C | 1 |
| Acquired Immunodeficiency Syndrome | 1 |
| Sepsis | 1 |
| Shock, Septic | 1 |
| Multiple Sclerosis | 1 |
| Neuromyelitis Optica | 1 |
| Breast Feeding | 1 |
| Diabetic Foot | 1 |
| Wounds and Injuries | 1 |
| Thrombotic Microangiopathies | 1 |
| Subarachnoid Hemorrhage | 1 |
| Insulin-Like Growth Factor I Deficiency | 1 |
| Hereditary Autoinflammatory Diseases | 1 |
| Schnitzler Syndrome | 1 |
| Behcet Syndrome | 1 |
| Marshall syndrome | 1 |

## Sponsors with the most

| Sponsor | Trials |
| --- | --- |
| University Hospital Center of Martinique | 8 |
| UNICANCER | 2 |
| Poitiers University Hospital | 1 |
| Institut Curie | 1 |
| Charite University, Berlin, Germany | 1 |
| Institut National de la Santé Et de la Recherche Médicale, France | 1 |
| University Hospital, Lille | 1 |
| Hospices Civils de Lyon | 1 |
| Nantes University Hospital | 1 |
| University Hospital, Bordeaux | 1 |
| University Hospital, Rouen | 1 |
| Esteve Pharmaceuticals, S.A. | 1 |
| University of Siena | 1 |
| Eidos Therapeutics, a BridgeBio company | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Food and beverage exporters in the United States](https://specstream.ai/data/businesses/food-and-beverage-exporters/united-states)
- [Mexican restaurants in the United States](https://specstream.ai/data/businesses/mexican-restaurants/united-states)
- [Sign makers in the United States](https://specstream.ai/data/businesses/sign-makers/united-states)
- [Assisted living facilities in the United States](https://specstream.ai/data/businesses/assisted-living-facilities/united-states)
- [Demolition contractors in the United States](https://specstream.ai/data/businesses/demolition-contractors/united-states)
- [Hyperbaric medicine centers in the United States](https://specstream.ai/data/businesses/hyperbaric-medicine-centers/united-states)
